Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Adolor Corp. (“Adolor” or the “Company”) (NASDAQ: ADLR) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) in an all-cash deal valued at about $190 million. Under the terms of the proposed transaction, Adolor stockholders will receive $4.25 in cash for each share of Adolor common stock they own. In addition to the upfront cash payment, each Adolor stockholder will receive an additional contingent payment of up to $4.50 a share, but only if certain regulatory approvals and future performance are met. According to Yahoo! Finance, at least one financial analyst has set a price target of $8.00 for Adolor. The proposed transaction is structured as a tender offer and may be effectuated without a shareholder vote.

Request more information now by clicking here: www.faruqilaw.com/ADLR

Whether Adolor’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Adolor’s shares and by how much this proposed transaction undervalues the Company to the detriment of Adolor’s shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in Adolor and wish to obtain additional information, please visit us at www.faruqilaw.com/ADLR or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Copyright Business Wire 2010

If you liked this article you might like

Insiders Trading TXI, WFM, ADLR, TRS

Insiders Trading TXI, WFM, ADLR, TRS

10 Best-Performing Stocks Under $5 in 2011

10 Best-Performing Stocks Under $5 in 2011

ValueAct Buys $3.9M More of Immucor

ValueAct Buys $3.9M More of Immucor

Health Winners & Losers: Bristol-Myers

Health Winners & Losers: Bristol-Myers

Progenics Has a Few Reasons to Live

Progenics Has a Few Reasons to Live